Send me a link:

*Text messaging rates may apply.

 Dow Down 0.13% Nasdaq Down 0.24%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.98 Down 0.01(1.15%) 1:10PM EDT - Nasdaq Real Time Price
Prev Close:0.99
Open:0.97
Bid:0.97 x 600
Ask:0.97 x 400
1y Target Est:3.50
Beta:0.93
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:0.97 - 1.00
52wk Range:0.65 - 4.00
Volume:127,908
Avg Vol (3m):794,287
Market Cap:56.68M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 1.15%56.68M
AGENDown 0.31%201.02M
DNDNDown 0.94%328.82M
STMLDown 5.22%146.21M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback